The World Health Organization (WHO) operates a prequalification programme to assess the quality, safety and efficacy of products that address global public health priorities. Pre-qualified products are listed on the WHO website as eligible for procurement, giving purchasing agencies such as UNICEF a range of quality-assured diagnostics, medicines and vaccines from which to choose. Charles River Associates was asked to support the development of a new financing arrangement that addressed the needs of all stakeholders, including industry groups, key partners and the WHO.
To read more, click the link below.
Upper Payment Limits (UPLs) explained
Regulatory shifts create new challenges for pharmaceutical stakeholders. Four states now have PDABs empowered to set UPLs for public payers, and three states...